Drug class
Low-ceiling diuretic and antihypertensive agent (ATC C03BX03)
Mechanism of action
Produces salidiuretic activity through an active sulfoconjugated metabolite that inhibits a sodium-dependent chloride/bicarbonate exchanger in the distal convoluted tubule. Vasodilator effects are complex and may involve prostaglandin synthesis, cyclic-GMP phosphodiesterase inhibition, calcium-channel effects and potassium-channel opening; the relative clinical contributions are not fully established.
General use cases
- Treatment of arterial hypertension in countries where cicletanine is authorised; antihypertensive use is supported by historical clinical and pharmacological literature, while current market availability is limited
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
